Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Related Keywords

Montreal ,Quebec ,Canada ,United States ,Massachusetts ,Philadelphia ,Pennsylvania ,Haverford College ,David Bharucha ,David Pitts ,Joseph Oliveto ,Milestone Pharmaceuticals Inc ,Company On Twitter At Milestonepharma ,Harvard Medical School ,Nasdaq ,Clinical Development At Allergan ,Exchange Commission ,Development At Allergan ,Milestone Pharmaceuticals ,Jefferson Medical University Philadelphia ,University Of Chicago ,Sinai School Of Medicine ,Chief Medical Officer ,Francis Plat ,Chief Scientific Officer ,Chief Executive Officer ,Vice President ,Clinical Development ,Forest Laboratories ,Sinai School ,Jefferson Medical University ,Massachusetts General Hospital ,Harvard Medical ,Molecular Biology ,Nasdaq Listing Rule ,Compensation Committee ,Private Securities Litigation Reform Act ,Nc ,